Investing Profile

Liam Ratcliffe

InvestorVCAngel

Head of Biotechnology at Access Biotechnology

Your Intro Paths to Liam Ratcliffe

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Liam Ratcliffe on

Current Investing Position

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Liam Ratcliffe is on these Sector & Stage Rankings

Liam Ratcliffe's Investments On Record (14)

Company	StageDateRound Size	Total Raised
Margin.	Pre SeedJan 2026$1M	$1M
Co-investors: Greg Maffei, Bill Ackman
Draig Therapeutics	Series AJun 2025$140M	$140M
Co-investors: Colleen Cuffaro (Canaan Partners)
Climb Bio	Series BMay 2021$60M Series AMar 2021$80M	$260M
Co-investors: Andrew Levin (RA Capital), Ohad Hammer (Pontifax Venture Capital)
Shoopy	SeedFeb 2021$250K	$250K
Passage Bio	Series BSep 2019$110M Series AFeb 2019$120M	$230M
Co-investors: Stephen Squinto (OrbiMed), Patrick Heron (Frazier Healthcare Partners), Carl Gordon (OrbiMed Advisors), Tom Woiwode (Versant Ventures)
CuraSen Therapeutics	Series AOct 2018$55M	$55M
Arvinas	Series CApr 2018$55M Series BOct 2015$42M	$140M
Co-investors: Tim Shannon (Canaan Partners), Colleen Cuffaro (Canaan Partners), Stephen Squinto (OrbiMed), Kush Parmar (5am Ventures), Martin Alexander Gershon (Endeavor Venture Funds), Daniel Wagner (Connecticut Innovations), Andrew Levin (RA Capital), Jakob Loven (Nextech Invest)
Aptinyx	Series BDec 2017$70M Series AMay 2016$65M	$140M
Co-investors: Adam Koppel (Bain Capital Life Sciences), James N. Topper (Frazier Healthcare Partners)